BCL6 and diffuse large B-cell lymphoma: EP300 function repression due to mutation or BCL6 suppression reduces H3K27ac, induces cell growth, and impairs the effect of BCL6 inhibitors and anti-CD20 antibodies to DLBCL cells [99–101].